Pharmacy Outlook: Stephen Ubl, PhRMA
Throughout 2021, lawmakers engaged in a robust debate over ways to lower the cost of prescription drugs. Our industry was at the center of this debate, fighting for reforms that would lower costs at the pharmacy while preserving patient access to life-saving medicines and future innovation. Unfortunately, Congress refused to take a holistic approach that
